Gastric Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Gastric Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: A Study of Paclitaxel With or Without Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Cancer [Phase 3]
Phase 3 trial assessing paclitaxel with or without ramucirumab in gastric or gastroesophageal junction adenocarcinoma has completed with res…
-
CLINICAL_TRIALS trial_result · 2021-06-14Clinical Trial Update: DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein [Phase 1]
Phase 1 clinical trial update for DS-8201a in patients with HER2-positive cancers completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: Study of Vismodegib in Advanced Gastric Adenocarcinoma Patients With SMO Overexpression [Phase 2]
Phase 2 trial update of vismodegib in advanced gastric adenocarcinoma with SMO overexpression completed.
-
CLINICAL_TRIALS trial_result · 2021-05-17Clinical Trial Update: Apatinib Plus Camrelizumab Combined With Docetaxel and S1 in First-line Treatment for Metastatic Gastric Cancer [Phase 2]
Phase 2 trial evaluating apatinib plus camrelizumab with docetaxel and S1 as first-line therapy for metastatic gastric/gastroesophageal junc…
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies [Phase 2]
Phase 2 trial update evaluating PDR001 plus LAG525 in patients with advanced solid and hematologic malignancies; results posted with complet…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer [Phase 1, Phase 2]
Phase 1/2 study of sacituzumab govitecan-hziy (IMMU-132) in adults with epithelial cancers; trial completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-29Clinical Trial Update: Personalized Targeted IMMUNOtherapy-based Regimens in Recurrent GASTric Adenocarcinoma (IMMUNOGAST) [Phase 2]
Phase 2 trial update on personalized immunotherapy-based regimens for recurrent gastric cancer is in early stages with status currently unkn…
-
CLINICAL_TRIALS trial_result · 2021-03-26Clinical Trial Update: Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer [Phase 2]
Phase 2 trial evaluating S-1 maintenance therapy in unresectable, locally advanced or metastatic gastric/GEJ adenocarcinoma has been complet…
-
CLINICAL_TRIALS trial_result · 2020-12-24Clinical Trial Update: Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Anti-Cancer Agents in Japanese Participants With Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 1]
Phase 1 trial evaluating andecaliximab as monotherapy and with anti-cancer agents in Japanese patients with gastric or gastroesophageal junc…
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating emibetuzumab in combination with ramucirumab in various advanced cancers, with completed status and results poste…
-
CLINICAL_TRIALS trial_result · 2020-11-19Clinical Trial Update: Ramucirumab/Paclitaxel as Second-line Treatment in Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma With Integrative Genomic Analysis [Phase 2]
Phase 2 trial evaluating ramucirumab plus paclitaxel as second-line therapy for metastatic gastric or gastroesophageal junction adenocarcino…
-
CLINICAL_TRIALS trial_result · 2020-10-01Clinical Trial Update: Camrelizumab Combined With Apatinib Mesylate Tablets and Nab-paclitaxel in the Second-line Treatment of Advanced Gastric Cancer [Phase 1, Phase 2]
Clinical trial evaluating camrelizumab plus apatinib and nab-paclitaxel for second-line advanced gastric cancer (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2020-08-26Clinical Trial Update: Neoadjuvant Chemoradiation Plus PD-1 Antibody(SHR-1210) in Locally Advanced Proximal Stomach Adenocarcinoma [Phase 2]
Phase 2 trial update evaluating neoadjuvant chemoradiation combined with PD-1 antibody SHR-1210 for locally advanced proximal stomach adenoc…
-
CLINICAL_TRIALS trial_result · 2020-08-07Clinical Trial Update: Efficacy and Safety of Anlotinib Hydrochloride Combined With Nivolumab in the Treatment of Gastric and Esophageal Cancer [Phase 2]
Phase 2 trial updating the efficacy and safety of anlotinib hydrochloride combined with nivolumab for gastric adenocarcinoma and esophageal …
-
CLINICAL_TRIALS trial_result · 2020-06-22Clinical Trial Update: Epacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction or Gastric Cancer [Phase 2]
Phase 2 trial updating epacadostat plus pembrolizumab in metastatic or unresectable gastroesophageal junction or gastric cancer (completed; …
-
CLINICAL_TRIALS trial_result · 2020-04-28Clinical Trial Update: Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 3]
Phase 3 trial update evaluating andecaliximab with mFOLFOX6 as first-line therapy for advanced gastric or gastroesophageal junction adenocar…
-
CLINICAL_TRIALS trial_result · 2020-03-13Clinical Trial Update: Study of Pembrolizumab (MK-3475) as First-Line Monotherapy and Combination Therapy for Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062) [Phase 3]
Phase 3 trial evaluating pembrolizumab as first-line monotherapy and in combination for advanced gastric or gastroesophageal junction adenoc…
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: The Purpose of This Study is to Evaluate the Efficacy and Safety of Sintilimab in Combination With Xelox as Neoadjuvant Therapy for Patients With Resectable Locally Advanced Gastric or Gastroesophageal Adenocarcinoma. [Phase 2]
A Phase 2 clinical trial evaluating sintilimab in combination with Xelox as neoadjuvant therapy for resectable locally advanced gastric or g…
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: S-1, Cisplatin-based Chemoradiotherapy, Induction Chemotherapy, Locally Advanced Gastric Adenocarcinoma [Phase 2]
Phase 2 clinical trial update evaluating S-1 and cisplatin-based chemoradiotherapy with induction chemotherapy for locally advanced gastric …
-
CLINICAL_TRIALS trial_result · 2020-01-07Clinical Trial Update: Trastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(AGC): Her+XELOX [Phase 2]
Phase 2 trial evaluating trastuzumab with XELOX in HER2-positive advanced gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-01-07Clinical Trial Update: Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATE [Phase 2]
Phase 2 clinical trial investigating sorafenib in advanced and/or recurrent gastric adenocarcinoma (STARGATE) has completed.
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line Chemotherapy [Phase 2]
Phase 2 trial evaluating AZD5363 in combination with paclitaxel for advanced gastric adenocarcinoma with PIK3CA mutation or amplification; s…
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: Study of AZD6094 (Volitinib) in Combination With Docetaxel, in Advanced Gastric Adenocarcinoma Patients With MET Overexpression as a Second-line Treatment [Phase 2]
A Phase 2 study evaluating AZD6094 (Volitinib) in combination with docetaxel for second-line treatment in advanced gastric adenocarcinoma wi…
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: Toripalimab Combined With Apatinib Mesylate for the Treatment of Gastric Adenocarcinoma in a Prospective Randomized Multicenter Phase II Clinical Study [Phase 2]
A prospective randomized multicenter Phase II study evaluating toripalimab combined with apatinib mesylate for gastric adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2019-11-13Clinical Trial Update: Apatinib Plus Irinotecan as Second-line Treatment in AGC or EGJA [Phase 2]
Phase 2 trial update evaluating apatinib plus irinotecan as a second-line treatment for metastatic gastric adenocarcinoma.